Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Crop Life Science (NSE:CLSL) Cash per Share Explanation
Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.
Crop Life Science Cash per Share Related Terms
Crop Life Science Cash per Share Historical Data
* Premium members only.
The historical data trend for Crop Life Science's Cash per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.
Crop Life Science's Cash per Share for the fiscal year that ended in Mar. 2026 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Crop Life Science (NSE:CLSL) has a Cash per Share of ₹1.49 as of Mar. 2026. Cash per share is the per-share value of a company's available cash. View historical data for Crop Life Science and its competitors.
Is Crop Life Science's Cash per Share too high?
Crop Life Science's current Cash per Share is ₹1.49. Overall, Crop Life Science has a GF Score™ of 74/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Crop Life Science's Cash per Share compare to CTVA and CF?
Crop Life Science's Cash per Share of ₹1.49 can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash per Share for an Agriculture company?
A good Cash per Share depends on the Agriculture industry context. However, Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash per Share mean?
A high Cash per Share can signal that a stock is expensive relative to its fundamentals. Cash per share is the per-share value of a company's available cash. View historical data for Crop Life Science and its competitors. Crop Life Science's current Cash per Share is ₹1.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Crop Life Science stock overvalued right now?
Based on GuruFocus' analysis, Crop Life Science (NSE:CLSL) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹55.94, compared to a current price of ₹74.50 — trading 33.2% above its estimated fair value. The current Cash per Share is ₹1.49. Crop Life Science's overall GF Score™ is 74/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash per Share calculated?
Cash per Share is calculated from a company's financial statements. For Crop Life Science (NSE:CLSL), the current Cash per Share is ₹1.49 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Crop Life Science (NSE:CLSL) Overvalued in 2026?
Based on GuruFocus' analysis, Crop Life Science stock appears to be overvalued.
The current stock price of ₹74.50 is trading 33.2% above its estimated GF Value™ of ₹55.94.
GuruFocus considers Crop Life Science to be Significantly Overvalued.
Key valuation signals for NSE:CLSL:
Cash per Share: ₹1.49
GF Value™: ₹55.94 vs. price of ₹74.50 (33.2% above fair value)
No single metric tells the full story. See the NSE:CLSL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Crop Life Science Ltd manufactures and distributes a broad range of crop protection chemicals, including pesticides, insecticides, fungicides, herbicides, micro fertilizers, bio-pesticides, bio-fertilizers, plant growth regulators, and soil plant health products. The company operates its manufacturing facility in Ankleshwar, Gujarat, leveraging technology to maintain quality standards. It serves agricultural markets within India and exports to countries including Indonesia, Bangladesh, Egypt, Myanmar, Vietnam, and Sudan. Segments include Agro chemicals and Agro trade. Revenue is generated through the sale of its agricultural chemicals and related products to farmers, distributors, and agri-businesses.
74GF Score
Get the complete analysis for NSE:CLSL
Cash per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:CLSL has been successfully added to your 
